Laskey Daniel, Housman Brian, Dawodu Gbalekan, Scheinin Scott
Thoracic Surgery Department, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, One Gustave L. Levy Place, Box 1023, New York, NY 10029, USA.
J Clin Med. 2023 Dec 29;13(1):192. doi: 10.3390/jcm13010192.
The use of intraoperative mechanical support during lung transplantation has traditionally been a controversial topic. Trends for intraoperative mechanical support strategies swing like a pendulum. Historically, cardiopulmonary bypass (CPB) was the modality of choice during transplantation. It provides full hemodynamic support including oxygenation and decarboxylation. Surgical exposure is improved by permitting the drainage of the heart and provides more permissive retraction. CPBs contain drainage reservoirs with hand-held pump suction catheters promoting blood conservation through collection and re-circulation. But CPB has its disadvantages. It is known to cause systemic inflammation and coagulopathy. CPB requires high doses of heparinization, which increases bleeding risks. As transplantation progressed, off-pump transplantation began to trend as a preferable option. ECMO, however, has many of the benefits of CPB with less of the risk. Outcomes were improved with ECMO compared to CPB. CPB has a higher blood transfusion requirement, a higher need for post-operative ECMO support, a higher re-intubation rate, high rates of kidney injury and need for hemodialysis, longer ICU stays, higher incidences of PGD grade 3, as well as overall in-hospital mortality when compared with ECMO use. The focus now shifts to using intraoperative mechanical support to protect the graft, helping to reduce ischemia-reperfusion injury and allowing for lung protective ventilator settings. Studies show that the routine use of ECMO during transplantation decreases the rate of primary graft dysfunction and many adverse outcomes including ventilator time, need for tracheostomy, renal failure, post-operative ECMO requirements, and others. As intraoperative planned ECMO is considered a safe and effective approach, with improved survival and better overall outcomes compared to both unplanned ECMO implementation and off-pump transplantation, its routine use should be taken into consideration as standard protocol.
在肺移植术中使用术中机械支持一直是一个有争议的话题。术中机械支持策略的趋势像钟摆一样摇摆不定。从历史上看,体外循环(CPB)是移植过程中的首选方式。它提供全面的血流动力学支持,包括氧合和脱羧作用。通过允许心脏引流改善手术暴露,并提供更宽松的牵开。CPB包含带有手持泵吸引导管的引流储液器,通过收集和再循环促进血液保存。但CPB有其缺点。已知它会引起全身炎症和凝血病。CPB需要高剂量的肝素化,这增加了出血风险。随着移植技术的发展,非体外循环移植开始成为一种更可取的选择。然而,体外膜肺氧合(ECMO)具有CPB的许多优点且风险较小。与CPB相比,ECMO改善了预后。与使用ECMO相比,CPB有更高的输血需求、更高的术后ECMO支持需求、更高的再次插管率、更高的肾损伤率和血液透析需求、更长的重症监护病房住院时间、更高的3级原发性移植功能障碍发生率以及总体住院死亡率。现在的重点转向使用术中机械支持来保护移植物,有助于减少缺血再灌注损伤,并允许采用肺保护性通气设置。研究表明,移植术中常规使用ECMO可降低原发性移植功能障碍的发生率以及许多不良后果,包括通气时间、气管切开需求、肾衰竭、术后ECMO需求等。由于术中计划性ECMO被认为是一种安全有效的方法,与非计划性ECMO实施和非体外循环移植相比,其生存率提高且总体预后更好,因此应考虑将其常规使用作为标准方案。